1. Home
  2. PCVX vs CBT Comparison

PCVX vs CBT Comparison

Compare PCVX & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • CBT
  • Stock Information
  • Founded
  • PCVX 2013
  • CBT 2019
  • Country
  • PCVX United States
  • CBT United States
  • Employees
  • PCVX N/A
  • CBT N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • CBT Major Chemicals
  • Sector
  • PCVX Health Care
  • CBT Industrials
  • Exchange
  • PCVX Nasdaq
  • CBT Nasdaq
  • Market Cap
  • PCVX 4.4B
  • CBT 3.9B
  • IPO Year
  • PCVX 2020
  • CBT N/A
  • Fundamental
  • Price
  • PCVX $32.70
  • CBT $78.14
  • Analyst Decision
  • PCVX Strong Buy
  • CBT Hold
  • Analyst Count
  • PCVX 10
  • CBT 3
  • Target Price
  • PCVX $136.50
  • CBT $92.33
  • AVG Volume (30 Days)
  • PCVX 1.3M
  • CBT 440.6K
  • Earning Date
  • PCVX 08-06-2025
  • CBT 08-04-2025
  • Dividend Yield
  • PCVX N/A
  • CBT 2.30%
  • EPS Growth
  • PCVX N/A
  • CBT N/A
  • EPS
  • PCVX N/A
  • CBT 7.65
  • Revenue
  • PCVX N/A
  • CBT $3,815,000,000.00
  • Revenue This Year
  • PCVX N/A
  • CBT N/A
  • Revenue Next Year
  • PCVX N/A
  • CBT $3.32
  • P/E Ratio
  • PCVX N/A
  • CBT $10.21
  • Revenue Growth
  • PCVX N/A
  • CBT N/A
  • 52 Week Low
  • PCVX $27.66
  • CBT $70.41
  • 52 Week High
  • PCVX $121.06
  • CBT $117.46
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 47.81
  • CBT 52.74
  • Support Level
  • PCVX $29.08
  • CBT $75.60
  • Resistance Level
  • PCVX $34.50
  • CBT $82.27
  • Average True Range (ATR)
  • PCVX 1.38
  • CBT 2.33
  • MACD
  • PCVX -0.18
  • CBT 0.44
  • Stochastic Oscillator
  • PCVX 48.69
  • CBT 65.18

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: